Influenza vaccines in China, "Dole hope to Happiness" mass start – inf
As the only Chinese mainland with a pandemic Influenza Vaccine production qualification of the enterprise, Beijing Sinovac Biotech Company Limited 8, to get from the U.S. CDC's influenza strain H1N1 influenza vaccine production, which means that influenza A H1N1 influenza vaccine in China, "Dole hope to Happiness" formal mass production start.
Reporter from the Ministry of Health was informed on the 8th, from U.S. Centers for Disease Control and Prevention and the United Kingdom Biological Products provides for the World Health Organization identified influenza H1N1 strain of influenza vaccine have delivered to 8 pm in Beijing, the vaccine virus strains were immediately sent to the relevant vaccine manufacturers.
Earlier, Britain and Biological Products available vaccine strains, respectively on June 3 and June 5 shipped Hualan Biological Engineering Co., Ltd. and Dalian Ya-feng biological Pharmacy Limited.
Wei-Dong Yin, general manager of Sinovac Beijing, said in the national response to influenza A H1N1 influenza joint prevention and control security group, and the Customs Department and other departments AQSIQ strong support from the U.S. CDC's influenza H1N1 influenza vaccine production strain NYMCX-179A 8-night arrival in Beijing Sinovac. Beijing Sinovac to get started quickly strain the seed strain prepared batch of work.
It is understood that a single batch of vaccine will take many virus inoculation, virus culture, virus inactivation, purification, ratio, sub-packaging and batch release and other steps in order to finally put into use. To achieve the protective effect of vaccines, and save antigen, Beijing Sinovac The Influenza H1N1 influenza vaccine using adjuvant vaccine production process. Goes well, the first batch of vaccine will be produced at the end of July.
Beijing Sinovac existing pandemic influenza vaccine production line of annual production capacity of 20 million to 30 million, is the only mainland China has qualified pandemic influenza vaccine production enterprise. As the pandemic influenza vaccine demand huge, Beijing Sinovac's production capacity is difficult to fully meet the needs of state and the public. To give as many people to provide protection, Beijing Sinovac decided several domestic manufacturers of seasonal influenza vaccine alliance to Beijing Sinovac since 2004 related to research carried out by the formation of the key pandemic influenza vaccine production technology and Cooperation Who share a common commitment to the vaccine, "Seoul hope to Happiness" production.
Wei-dong told reporters, "Seoul hope to Happiness" the production and testing will be strictly in accordance with national Food And Drug Administration approved the "pandemic influenza virus vaccine manufacture and test procedures" to. State Food and Drug Administration has issued a timely manner, "the special approval of pandemic influenza vaccine program of emergency", so that co-production of the vaccine according to the law, to ensure the production of vaccine science, legal, orderly and efficient manner, to ensure the safety of vaccine use sex.
2004, Beijing Sinovac and China Centre for Disease Control and Prevention, in cooperation Science and Technology, Ministry of Health with the support of the beginning of a pandemic influenza prototype vaccines, and the State Development and Reform Commission in support of building a new Automatic sub-packaging line. In 2008 the vaccine was successful completion of clinical studies and the State Food and Drug Administration issued production licenses.
Beijing Sinovac has been committed to human vaccines and related product development, production and Sell . Currently marketed products include liver inactivated influenza vaccine, "child Seoul to Happiness", a hepatitis B vaccine, "times of Seoul to Happiness," and so on.
I am an expert from fiber-optic-multiplexer.com, while we provides the quality product, such as Fiber Optic Modem , Multiservice Multiplexer, pdh multiplexer,and more.
Processing your request, Please wait....
